Influence of a Bitter Compound and Bittermasking Compound on Gastric pH
NCT ID: NCT02372188
Last Updated: 2015-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
25 participants
INTERVENTIONAL
2013-09-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bitter Tastants and Reflux
NCT03777787
Esophageal capsaïcin Infusion and Mucosal Integrity
NCT02603783
Hyaluronic Acid in Patients With Gastroesophageal Reflux Disease
NCT05561179
Efficacy and Speed of Action of a Product to Control Gastric Hydration and Gastroesophageal Reflux
NCT05060744
Fermented Soy and Heartburn Symptom Relief
NCT03867591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the non-invasive measurement of the gastric pH, the Heidelberg Detection System (Heidelberg Medical Inc., USA) was used which has been successfully used in our working group.
This system consists of a pH-sensitive capsule (called a Heidelberg capsule), with a length of 2 cm, that has to be swallowed and contains a miniature radio transmitter. This system allows the detection of the actual gastric pH of the volunteer over a specific time period \[Liszt et al 2012, Rubach et al. 2014\].
Prior to each test, Heidelberg capsules were activated for 5 min in a 0.9% sterile NaCl solution and calibrated using two calibration points, pH 1 and 7. Afterward, the subjects swallowed the capsule lay down on the left side. The capsule sends a signal to a transceiver, which has to be placed on the abdomen of the volunteer. The transceiver sends the signal to the recorder connected to a computer. The data can be collected and shown as a gastrogram on the computer screen, where the pH is drawn over time. When the intragastric pH was constant between pH 0.5 and 2.5 for at least 3 min, the capsule was considered to be in the stomach. Afterward, each trial started with the administration of 5 mL of a saturated sodium bicarbonate solution (NaHCO3). This alkaline challenge triggers a rise in gastric pH between around pH 6 to 7 and subsequently leads to the secretion of stomach acid by the parietal cells. The test solutions were administered 5 minutes after or 30 min before the alkaline challenge.
Reacidification time as well as the time until start of the reacidification has been analyzed.
Ratings of hunger were assessed before and after each gastric pH measurement by means of visual analog scales (VAS). Before and after each intervention blood samples were drawn to quantify satiety hormones (ghrelin, PYY, GLP-1, serotonin). Ad libitum energy and macronutrient intakes from a standardized breakfast served after each treatment were calculated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Water
125 mL water are administered during or before gastric pH measurement
water
Control
Caffeine
150 mg Caffeine and 125 mL water are administered during or before gastric pH measurement
caffeine
Caffeine + homoeriodictyol sodium salt
150 mg Caffeine + 30 mg homoeriodictyol sodium salt and 125 mL water are administered during or before gastric pH measurement
caffein + homoeriodictyol sodium salt
homoeriodictyol sodium salt
30 mg homoeriodictyol sodium salt and 125 mL water are administered during the gastric pH measurement
homoeriodictyol sodium salt
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
water
Control
caffeine
caffein + homoeriodictyol sodium salt
homoeriodictyol sodium salt
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sensorically untrained
* BMI: 19 - 26 kg/m2
Exclusion Criteria
* metabolic diseases,
* H.pylori infection,
* smoking,
* increased sensibility towards caffeine,
* intake of antibiotics in the last 2 months,
* medication except for oral contraceptives,
* drug- or alcohol-abuse,
* heart disease, high blood pressure,
* pregnancy
20 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Univ.-Prof. Dr. Veronika Somoza
Univ.-Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veronika Somoza, Prof. PhD
Role: PRINCIPAL_INVESTIGATOR
University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christian Doppler Laboratory for Bioactive Aroma Compounds
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Liszt KI, Walker J, Somoza V. Identification of organic acids in wine that stimulate mechanisms of gastric acid secretion. J Agric Food Chem. 2012 Jul 18;60(28):7022-30. doi: 10.1021/jf301941u. Epub 2012 Jul 5.
Rubach M, Lang R, Bytof G, Stiebitz H, Lantz I, Hofmann T, Somoza V. A dark brown roast coffee blend is less effective at stimulating gastric acid secretion in healthy volunteers compared to a medium roast market blend. Mol Nutr Food Res. 2014 Jun;58(6):1370-3. doi: 10.1002/mnfr.201300890. Epub 2014 Feb 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GAS-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.